{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T05:13:08Z","timestamp":1721452388859},"reference-count":27,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7703","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T14:01:29Z","timestamp":1561384889000},"source":"Crossref","is-referenced-by-count":0,"title":["Curative effect of \u03b2\u2011blocker on various ejection fractions of patients with atrial fibrillation"],"prefix":"10.3892","author":[{"given":"Wei","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Likun","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"key":"key20200713100427_b1-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates","author":"Kannel","year":"1998","journal-title":"Am J Cardiol 82 (8A)"},{"key":"key20200713100427_b2-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"key":"key20200713100427_b3-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: The Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"key20200713100427_b4-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","article-title":"Atrial fibrillation and heart failure: Treatment considerations for a dual epidemic","volume":"119","author":"Anter","year":"2009","journal-title":"Circulation"},{"key":"key20200713100427_b5-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1161\/CIRCULATIONAHA.106.614560","article-title":"Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure","volume":"114","author":"Hoppe","year":"2006","journal-title":"Circulation"},{"key":"key20200713100427_b6-etm-0-0-7703","first-page":"582","article-title":"Heart Failure with Preserved Ejection Fraction: Diagnosis and Management","volume":"96","author":"Gazewood","year":"2017","journal-title":"Am Fam Physician"},{"key":"key20200713100427_b7-etm-0-0-7703","first-page":"50","article-title":"2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS","volume":"70","author":"Kirchhof","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"key20200713100427_b8-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/eurheartj\/ehi166","article-title":"Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: Results from COMET","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"key":"key20200713100427_b9-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/01.CIR.100.4.376","article-title":"Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction","volume":"100","author":"Pedersen","year":"1999","journal-title":"Circulation"},{"key":"key20200713100427_b10-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ahj.2005.06.036","article-title":"Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"152","author":"Ducharme","year":"2006","journal-title":"Am Heart J"},{"key":"key20200713100427_b11-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jacc.2004.09.076","article-title":"Antiarrhythmic effect of carvedilol after acute myocardial infarction: Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial","volume":"45","author":"McMurray","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key20200713100427_b12-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of \u03b2 blockers in patients with heart failure plus atrial fibrillation: An individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"key":"key20200713100427_b13-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ahj.2017.12.001","article-title":"A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation\/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial","volume":"199","author":"Piccini","year":"2018","journal-title":"Am Heart J"},{"key":"key20200713100427_b14-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1751-7133.2012.00309.x","article-title":"Heart rate control in patients with chronic atrial fibrillation and heart failure","volume":"19","author":"Silvet","year":"2013","journal-title":"Congest Heart Fail"},{"key":"key20200713100427_b15-etm-0-0-7703","article-title":"Nomenclature and criteria for diagnosis of diseases of the heart and great vessels\/the Criteria Committee of the New York Heart Association","author":"Dolgin","year":"1994","edition":"9th"},{"key":"key20200713100427_b16-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: Guidelines for the six-minute walk test","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"key20200713100427_b17-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1161\/CIRCRESAHA.111.245092","article-title":"Treatment of chronic heart failure with \u03b2-adrenergic receptor antagonists: A convergence of receptor pharmacology and clinical cardiology","volume":"109","author":"Bristow","year":"2011","journal-title":"Circ Res"},{"key":"key20200713100427_b18-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"key20200713100427_b19-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","article-title":"2009 Focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"key20200713100427_b20-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 Comprehensive Heart Failure Practice Guideline","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J Card Fail"},{"key":"key20200713100427_b21-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"e000520","DOI":"10.1136\/openhrt-2016-000520","article-title":"Relationships among achieved heart rate, \u03b2-blocker dose and long-term outcomes in patients with heart failure with atrial fibrillation","volume":"3","author":"Miller","year":"2016","journal-title":"Open Heart"},{"key":"key20200713100427_b22-etm-0-0-7703","first-page":"f55","article-title":"Benefits of \u03b2 blockers in patients with heart failure and reduced ejection fraction: Network meta-analysis","author":"Chatterjee","year":"2013","journal-title":"BMJ 346 (jan16 1)"},{"key":"key20200713100427_b23-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jchf.2015.10.008","article-title":"Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial","volume":"4","author":"Edelmann","year":"2016","journal-title":"JACC Heart Fail"},{"key":"key20200713100427_b24-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","article-title":"Effects of carvedilol on heart failure with preserved ejection fraction: The Japanese Diastolic Heart Failure Study (J-DHF)","volume":"15","author":"Yamamoto","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"key20200713100427_b25-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"key":"key20200713100427_b26-etm-0-0-7703","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/2229-3485.210449","article-title":"Evaluation of efficacy of metoprolol in patients having heart failure with preserved ejection fraction: A randomized, double-blind, placebo-controlled pilot trial","volume":"8","author":"Mittal","year":"2017","journal-title":"Perspect Clin Res"},{"key":"key20200713100427_b27-etm-0-0-7703","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jacc.2008.09.031","article-title":"Clinical effectiveness of beta-blockers in heart failure: Findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry","volume":"53","author":"Hernandez","year":"2009","journal-title":"J Am Coll Cardiol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T04:42:17Z","timestamp":1721450537000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":27,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7703","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,24]]}}}